WO2010030220A1 - Cereal suspension - Google Patents
Cereal suspension Download PDFInfo
- Publication number
- WO2010030220A1 WO2010030220A1 PCT/SE2009/000409 SE2009000409W WO2010030220A1 WO 2010030220 A1 WO2010030220 A1 WO 2010030220A1 SE 2009000409 W SE2009000409 W SE 2009000409W WO 2010030220 A1 WO2010030220 A1 WO 2010030220A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cereal
- suspension
- cereals
- glucane
- product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/137—Thickening substances
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/154—Milk preparations; Milk powder or milk powder preparations containing additives containing thickening substances, eggs or cereal preparations; Milk gels
- A23C9/1544—Non-acidified gels, e.g. custards, creams, desserts, puddings, shakes or foams, containing eggs or thickening or gelling agents other than sugar; Milk products containing natural or microbial polysaccharides, e.g. cellulose or cellulose derivatives; Milk products containing nutrient fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/104—Fermentation of farinaceous cereal or cereal material; Addition of enzymes or microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/115—Cereal fibre products, e.g. bran, husk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the invention relates to a method for the production of a ⁇ -glucane containing cereal suspension as well as the ⁇ -glucane containing cereal suspension and products comprising ⁇ -glucane containing cereal suspensions.
- beta glucanes due to the health enhancing values of the beta glucanes.
- the beta glucanes have been linked to health effects such as being good for the cardiovascular system, gastrointestinal tract, positive weight control through a sated feeling as well as reducing the GI-load by lowering the glucose and the insulin levels.
- WO90/10748 discloses a process for the manufacturing of a cellulose-containing product, whereby the whole biomass is obtained from annual cellulose-producing plant, such as cereals are treated with alkali.
- WO95/07628 relates to a homogenous and stable cereal suspension tasting and smelling like natural oats, wherein said suspension have been treated with specific ⁇ - and ⁇ - amylases in separate steps and whereby the process give rise to an cereal suspension having at least partly intact ⁇ -glucanes from oat.
- WO00/24270 discloses a method for producing from an oat flour fraction, a water soluble beta-glucane composition having a high beta glucane/glucose weight ratio such as from 15:1, or more, wherein said method comprises the use of ⁇ -amylase in an amount sufficient to transform more than 50 % by weight of starch contained in the oats flour fraction to maltose.
- the enzyme pullulase and/or protease may be used in combination with ⁇ -amylase.
- the invention relates to a new improved cereal suspension being prepared by a new invented method.
- the invented method it may at least be possible to control the consistency of the developed cereal suspension as well as the taste and sweetness of the suspension. Additionally, the invented cereal suspension, lower the glucose response in a mammal, such as a human being compared to conventional cereal suspensions.
- Conventional cereal suspension such as oat suspensions does not have a defined size of the beta-glucanes present within the suspension.
- the method comprises steps in which amylases are used in a specific combination which gives rise to steps in which the beta glucanes present within the oats efficiently and fast are degraded into small pieces of beta-glucanes, are systemically degraded as well as a sweet taste is achieved. The process is also very cost effective. After the treatment of the cereal suspension ⁇ -glucanes are added from another cereal source and thereby it is possible to control the consistency efficiently.
- the invention in a first aspect relates to a method for the production of a ⁇ - glucane containing cereal suspension comprising the steps of; providing dry-or wet- grinded rolled cereals, suspending said first cereals if the cereals has been dry- grinded in a liquid, treating said cereals with at least three different enzymes, wherein said enzymes are ⁇ - and ⁇ - amylase enzymes, wherein the enzymes degrades the fibres, adding whereby you thereafter may add ⁇ -glucanes from a second cereal source, in an amount of from 0.011 to 1,0 % and obtaining the ⁇ - glucane containing cereal suspension.
- Such a suspension will have a number of improved properties such as reduction of the LDL (bad cholestrerol) cholesterol content, increased viscosity when the cereal suspension passes the small intestine which delays the adsorption of fats and sugars, lower the glucose response compared to conventional cereal suspension.
- LDL bad cholestrerol
- conventional cereal suspensions does not contain substantially intact ⁇ -glucanes.
- the invented suspension gives a good feeling of satiation which aids in limiting the caloric intake as well as a number of other health enhancing effects.
- the invention in a second aspect relates to a ⁇ -glucane cereal suspension product comprising a first cereal suspension to which ⁇ -glucanes from a second source of cereals has been added, wherein the amount of ⁇ -glucanes are from 0.01 to 1.0 %, wherein the cereal suspension and the ⁇ -glucanes are from different cereal sources.
- the ⁇ -glucan cereal suspension may be obtained by the above described method.
- the invention relates to a product comprising a ⁇ -glucane cereal suspension.
- Fig 1 illustrates one way to produce the invented cereal suspension as explained in EXAMPLE 1.
- the invention relates to a ⁇ -glucane cereal suspension, wherein said suspension being based on a cereal suspension from a first cereal source, wherein the major part of the fibres such as the ⁇ -glucanes has been removed or degraded and to which ⁇ -glucanes from a second source has been added to an amount of 0.01 to 1.0 %, such as 0.05, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9 or 1.0%. Examples are 0.2-1.0 % or 0.5-1.0 %
- the ⁇ -glucane cereal suspension has a Brix number from 9-11, such as to 9.5, 9.6, 9.7, 9.
- the cereal source may be different kinds of wheat, such as durum, dinkel and bulgur, triticale, oat, rye, corn, grain sorghum, pearl millet or barley, such as the suspension may be produced from oat and the ⁇ -glucanes may be from barley, rye or another oat source. Other sources may be leguminous plants. One specific example being the combination of wheat to which ⁇ -glucanes will be added.
- the cereal source may be any kind of pure cereal source or any mixture of given cereal sources.
- the second source of cereals which will be added after the ⁇ -glucanes have been removed or degraded from the first source may contain ⁇ -glucanes having a size of at least 400 000 Dalton, such as 500 000, 600 000, 700 000, 800 000 or more or having a size range of from 400 000 to 1 500 000 or 500 000 to 1 500 000 or 700 000 to 1500 000 Dalton.
- the size may vary depending on the cereal source and there will always be traces or minor amounts have a size less than the sizes mentioned above.
- the invention also relates to a method in which the product defined above may be produced.
- the method comprises the steps of providing dry-or wet-grinded rolled cereals.
- the cereals may then be added to a vacuum container to which a liquid such as water will be added and the cereals suspended into a suspension.
- the vacuum container secures that the cereal suspension will no be exposed to air and no or just minor oxidation may occur.
- the cereal suspension will be treated with a subset of enzymes, wherein the order of the enzymes may be as follows: ⁇ -amylase enzyme followed by a ⁇ -amylase enzyme followed by an ⁇ -amylase enzyme.
- ⁇ -amylase Fungamyl® obtainable from Novo Nordisk AS and Maltogenase® obtainable from Danisco AS
- example of a ⁇ -amylase is DIAZYME®BB obtainable from Danisco AS.
- the ⁇ -glucanes of the cereal suspension will be partly or completely degraded during the enzymatic treatment, dependent on the purity of the enzymes.
- the suspension may be passed into a colloid miller and milled into a homogenous suspension and the following treatment with at least a ⁇ -amylase for an additional time period, wherein the Brix number increases.
- the enzymes may then be inactivated by for example an increase in temperature, such as above 100 0 C.
- the fibre fraction may then be removed from the cereal suspension, wherein the fibre fraction comprises ⁇ -glucanes as well as other fibres by decanting.
- the cereal suspension may be treated by at least an additional ⁇ -amylase, which will hydrolyse 1,4-alpha-glucosidic linkages in starch, partially hydrolysed starch and low-molecular weight oligosaccharides, including maltotriose. Maltose units are removed in a stepwise manner from the non-reducing chain ends.
- Example of an ⁇ -amylase suitable to be used in the final enzymatic treatment being MaltogenaseTM obtainable from Novo Nordisk AS. All the steps used in the process are to achieve the goal of increasing the brix value to a value which gives a desired taste.
- the enzymatic steps will be followed by heat inactivating steps such as UHT treatment steps.
- ⁇ -glucans Prior to that the product is finalised when ⁇ -glucans are added, wherein said ⁇ -glucans are from another source than the cereals that have been treated in the method.
- the ⁇ -glucans may be the Barley B ⁇ - Fibre obtainable from Culinar having a defined size of the beta-glucanes.
- the ⁇ -glucane cereal suspension has a number of improved properties, such a well defined suspension will be more attractive to use as a health improving cereal suspension compared to other cereal suspensions.
- Such a suspension will have a number of improve properties such as it reduces the LDL (bad cholestrerol) cholesterol content, increased viscosity when the cereal suspension passes the small intestine which delays the adsorption of fats and sugars, lower the glucose response compared to conventional cereal suspension, gives a good feeling of satiation which aids in limiting the caloric intake as well as a number of other health enhancing effects.
- the ⁇ -glucane cereal suspension may also comprise one or more added ingredients such as taste, colour, minerals, vitamins, vanilla, cacao, cinnamon, herbs, ginger, coffe, fruit, berries etc. Another example is inuline.
- the ⁇ -glucan cereal suspension product may be ice-cream, gruel, yoghurt, milkshake, smoothie, a health drink or any other drink.
- the ⁇ -glucan cereal suspension product may be replacement product for an animal milk product such as a cow milk product.
- Fig 1 shows how the ⁇ -glucane containing oat suspension was prepared in the example.
- the oat suspension was treated for 8 minutes and then transferred to a colloid mill (4) were the suspension was milled for 20 minutes and transferred to container 5 to which 91 ml of Fungamyl (6) and the treatment contained for additional 22 minutes.
- the enzymes were then inactivated at 110 degree C (7) followed by a flashing step at 75 0 C (8).
- the flashing was followed by a step of decanting (9) wherein the fibre fraction containing ⁇ -glucanes were removed from the oat suspension followed by e cooling step (10) performed at a temperature of about 58-60 0 C.
- the oat suspension was transferred to a container (11) and 220 ml of Maltogenase (12) was added and the oat suspension was perheated (13) and incubated until preferred taste is obtained having a brix value of about 10 when an UHT treatment (14) at 140 0 C were performed to inhibit the enzymes.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Dispersion Chemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Cereal-Derived Products (AREA)
Abstract
The invention relates to an improved cereal suspension that is manufactured by a novel method. Due to the novel method, the consistency as well as the taste and the sweetness of the.suspension - can- be controlled. The method of manufacture includes steps where amylases are used in specific combinations, resulting in the degradation of beta-glucans in the oat and in an increase in the sweetness of the suspension. After the enzymatic treatment, beta-glucans from another source are added, a measure which enables an efficient control of the consistency of the suspension. The invention also relates to a cereal suspension that contains beta-glucans.
Description
CEREAL SUSPENSION
FIELD OF INVENTION
The invention relates to a method for the production of a β-glucane containing cereal suspension as well as the β-glucane containing cereal suspension and products comprising β-glucane containing cereal suspensions.
BACKGROUND OF THE INVENTION
For a number of years focus has been on beta glucanes due to the health enhancing values of the beta glucanes. The beta glucanes have been linked to health effects such as being good for the cardiovascular system, gastrointestinal tract, positive weight control through a sated feeling as well as reducing the GI-load by lowering the glucose and the insulin levels.
WO90/10748 discloses a process for the manufacturing of a cellulose-containing product, whereby the whole biomass is obtained from annual cellulose-producing plant, such as cereals are treated with alkali.
WO95/07628 relates to a homogenous and stable cereal suspension tasting and smelling like natural oats, wherein said suspension have been treated with specific α- and β- amylases in separate steps and whereby the process give rise to an cereal suspension having at least partly intact β-glucanes from oat.
WO00/24270 discloses a method for producing from an oat flour fraction, a water soluble beta-glucane composition having a high beta glucane/glucose weight ratio such as from 15:1, or more, wherein said method comprises the use of β-amylase in an amount sufficient to transform more than 50 % by weight of starch contained in the oats flour fraction to maltose. The enzyme pullulase and/or protease may be used in combination with α-amylase.
The development of different functional food products has increased during the years. However, there is still a need of developing new products having improved properties as well as new properties and it is often difficult to produce cereal based suspension products with specific properties such as the consistency as well as giving a product a fat taste without adding any fat.
SUMMARY OF THE INVENTION
The invention relates to a new improved cereal suspension being prepared by a new invented method. By the invented method it may at least be possible to control the consistency of the developed cereal suspension as well as the taste and sweetness of the suspension. Additionally, the invented cereal suspension, lower the glucose response in a mammal, such as a human being compared to conventional cereal suspensions. Conventional cereal suspension such as oat suspensions does
not have a defined size of the beta-glucanes present within the suspension. The method comprises steps in which amylases are used in a specific combination which gives rise to steps in which the beta glucanes present within the oats efficiently and fast are degraded into small pieces of beta-glucanes, are systemically degraded as well as a sweet taste is achieved. The process is also very cost effective. After the treatment of the cereal suspension β-glucanes are added from another cereal source and thereby it is possible to control the consistency efficiently.
In a first aspect the invention relates to a method for the production of a β- glucane containing cereal suspension comprising the steps of; providing dry-or wet- grinded rolled cereals, suspending said first cereals if the cereals has been dry- grinded in a liquid, treating said cereals with at least three different enzymes, wherein said enzymes are α- and β- amylase enzymes, wherein the enzymes degrades the fibres, adding whereby you thereafter may add β-glucanes from a second cereal source, in an amount of from 0.011 to 1,0 % and obtaining the β- glucane containing cereal suspension.
Such a suspension will have a number of improved properties such as reduction of the LDL (bad cholestrerol) cholesterol content, increased viscosity when the cereal suspension passes the small intestine which delays the adsorption of fats and sugars, lower the glucose response compared to conventional cereal suspension. Normally, conventional cereal suspensions does not contain substantially intact β-glucanes. The invented suspension gives a good feeling of satiation which aids in limiting the caloric intake as well as a number of other health enhancing effects.
In a second aspect the invention relates to a β-glucane cereal suspension product comprising a first cereal suspension to which β-glucanes from a second source of cereals has been added, wherein the amount of β-glucanes are from 0.01 to 1.0 %, wherein the cereal suspension and the β-glucanes are from different cereal sources. The β-glucan cereal suspension may be obtained by the above described method. In a third aspect the invention relates to a product comprising a β-glucane cereal suspension.
BRIEF DESCRIPTION OF DRAWINGS
Fig 1 illustrates one way to produce the invented cereal suspension as explained in EXAMPLE 1.
DETAILED DESCRIPTION OF THE INVENTION
The invention relates to a β-glucane cereal suspension, wherein said suspension being based on a cereal suspension from a first cereal source, wherein the major part of the fibres such as the β-glucanes has been removed or degraded and to which β-glucanes from a second source has been added to an amount of 0.01 to 1.0 %, such as 0.05, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9 or 1.0%. Examples are 0.2-1.0 % or 0.5-1.0 % The β-glucane cereal suspension has a Brix number from 9-11, such as to 9.5, 9.6, 9.7, 9. 8, 9.9, 10.0, 10.1, 10.1, 10.3, 10.4, 10.5, 10.6, 10.7, 10.8 or 10.9. The brix number is an indication on, how much sucrose a product contain. The cereal source may be different kinds of wheat, such as durum, dinkel and bulgur, triticale, oat, rye, corn, grain sorghum, pearl millet or barley, such as the suspension may be produced from oat and the β-glucanes may be from barley, rye or another oat source. Other sources may be leguminous plants. One specific example being the combination of wheat to which β-glucanes will be added. The cereal source may be any kind of pure cereal source or any mixture of given cereal sources. The second source of cereals which will be added after the β-glucanes have been removed or degraded from the first source may contain β-glucanes having a size of at least 400 000 Dalton, such as 500 000, 600 000, 700 000, 800 000 or more or having a size range of from 400 000 to 1 500 000 or 500 000 to 1 500 000 or 700 000 to 1500 000 Dalton. However, the size may vary depending on the cereal source and there will always be traces or minor amounts have a size less than the sizes mentioned above.
The invention also relates to a method in which the product defined above may be produced. The method comprises the steps of providing dry-or wet-grinded rolled cereals. The cereals may then be added to a vacuum container to which a liquid such as water will be added and the cereals suspended into a suspension. The vacuum container secures that the cereal suspension will no be exposed to air and no or just minor oxidation may occur. The cereal suspension will be treated with a subset of enzymes, wherein the order of the enzymes may be as follows: α-amylase enzyme followed by a β-amylase enzyme followed by an α-amylase enzyme. By the use of different treatments with different enzymes different cereal suspensions will be created, wherein the brix value of the cereal suspensions will increase during the treatment and the cereal suspension will obtain a taste which is sweeter and sweeter. Example of an α-amylase is Fungamyl® obtainable from Novo Nordisk AS and Maltogenase® obtainable from Danisco AS and example of a β-amylase is DIAZYME®BB obtainable from Danisco AS. The β-glucanes of the cereal suspension will be partly or completely degraded during the enzymatic treatment, dependent on the purity of the enzymes. After a first treatment with at least an α- amylase the suspension may be passed into a colloid miller and milled into a homogenous suspension and the following treatment with at least a β-amylase for
an additional time period, wherein the Brix number increases. The enzymes may then be inactivated by for example an increase in temperature, such as above 100 0C. The fibre fraction may then be removed from the cereal suspension, wherein the fibre fraction comprises β-glucanes as well as other fibres by decanting. After treatment with at least a β-amylase the cereal suspension may be treated by at least an additional α-amylase, which will hydrolyse 1,4-alpha-glucosidic linkages in starch, partially hydrolysed starch and low-molecular weight oligosaccharides, including maltotriose. Maltose units are removed in a stepwise manner from the non-reducing chain ends. Example of an α-amylase suitable to be used in the final enzymatic treatment being Maltogenase™ obtainable from Novo Nordisk AS. All the steps used in the process are to achieve the goal of increasing the brix value to a value which gives a desired taste. The enzymatic steps will be followed by heat inactivating steps such as UHT treatment steps. Prior to that the product is finalised when β-glucans are added, wherein said β-glucans are from another source than the cereals that have been treated in the method. The β-glucans may be the Barley Bβ- Fibre obtainable from Culinar having a defined size of the beta-glucanes.
The β-glucane cereal suspension has a number of improved properties, such a well defined suspension will be more attractive to use as a health improving cereal suspension compared to other cereal suspensions. Such a suspension will have a number of improve properties such as it reduces the LDL (bad cholestrerol) cholesterol content, increased viscosity when the cereal suspension passes the small intestine which delays the adsorption of fats and sugars, lower the glucose response compared to conventional cereal suspension, gives a good feeling of satiation which aids in limiting the caloric intake as well as a number of other health enhancing effects.
The β-glucane cereal suspension may also comprise one or more added ingredients such as taste, colour, minerals, vitamins, vanilla, cacao, cinnamon, herbs, ginger, coffe, fruit, berries etc. Another example is inuline.
The β-glucan cereal suspension product may be ice-cream, gruel, yoghurt, milkshake, smoothie, a health drink or any other drink. The β-glucan cereal suspension product may be replacement product for an animal milk product such as a cow milk product.
EXAMPLES
EXAMPLE 1
Production of an oat suspension.
Fig 1 shows how the β-glucane containing oat suspension was prepared in the example. 480 kg of oat flakes (Frebaco AB, Linkδping, Sweden) and the enzyme Fungamyl® obtainable from Novo Nordisk AS was added in an amount of 91 ml was added to the vacuum container as well as 450 ml of DIAZYME®BB obtainable from Danisco AS and (2) into which 3281 kg water was pumped from container (3), wherein container 3 has a temperature of 57 0C. The oat suspension was treated for 8 minutes and then transferred to a colloid mill (4) were the suspension was milled for 20 minutes and transferred to container 5 to which 91 ml of Fungamyl (6) and the treatment contained for additional 22 minutes. The enzymes were then inactivated at 110 degree C (7) followed by a flashing step at 75 0C (8). The flashing was followed by a step of decanting (9) wherein the fibre fraction containing β-glucanes were removed from the oat suspension followed by e cooling step (10) performed at a temperature of about 58-60 0C. The oat suspension was transferred to a container (11) and 220 ml of Maltogenase (12) was added and the oat suspension was perheated (13) and incubated until preferred taste is obtained having a brix value of about 10 when an UHT treatment (14) at 140 0C were performed to inhibit the enzymes. Again a step of flashing were done (15) followed by homogenisation followed by a final step of cooling down the product. To the oat suspension was then intact β-glucanes added in step 11 after treatment with Maltogenase. Optionally other ingredients such as those mentioned above may be added at the same step as the β-glucanes or at a different step.
The result is shown below.
Claims
1. A method for the production of a β-glucane containing cereal suspension comprising the steps of; a. Providing dry-or wet-grinded rolled cereals, b. Suspending said first cereals if the cereals has been dry-grinded in a liquid, c. Treating said cereals with an α-amylase, d. Treating said cereals with a β-amylase, , wherein step c always is prior to step d, e. Treating the cereals with an α-amylase after step d), f. Removing unsoluble fibres, g. Adding β-glucans from second cereal source, in an amount of from 0.011 to 1,0 % and h. Obtaining the β-glucane containing cereal suspension.
2. The method according to claim 1, wherein said process comprises an additional step of inactivating said enzymes after step d.
3. The method according to any of claims 1-2, herein said first cereals in step b is suspended in water.
4. The method according to any of preceding steps, wherein said β-glucans from said second cereal source have a size of at least 400 000 Dalton.
5. The method according to any of preceding claims, wherein said enzymes are different enzymes.
6. The method according to any of preceding claims, wherein said inactivating step is performed by UHT treatment (Ultra High Temperature).
7. The β-glucane cereal suspension product according to claim 6, wherein the Brix number of the product is from 9-11.
8. The method according to any of preceding claims, wherein said process comprises the steps of: a. Adding one or more ingredients to said cereal suspension in step g.
9. The method according to any of preceding claims, wherein the cereals are selected from the group consisting of wheat, triticale, oat, rye, corn, grain sorghum, pearl millet or barley.
10. A β-glucane cereal suspension product comprising a first cereal suspension to which β-glucanes has been added from a second source of cereals, wherein the amount of β-glucanes are from 0.01 to 1.0 %.
11. The β-glucane cereal suspension product according to claim 10, wherein said β-glucans from said second cereal source have a size of at least 400 000 Dalton.
12. A product comprising the β-glucane cereal suspension according to any of claims 1-11.
13. The product according to claim 12, wherein said product is selected from the group consisting of ice-cream, gruel, yoghurt, smoothie, milkshake, health drink.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09813303A EP2339929A4 (en) | 2008-09-15 | 2009-09-15 | SUSPENSION OF CEREALS |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0801966A SE0801966L (en) | 2008-09-15 | 2008-09-15 | cereal suspension |
| SE0801966-3 | 2008-09-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2010030220A1 true WO2010030220A1 (en) | 2010-03-18 |
Family
ID=41435137
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/SE2009/000409 Ceased WO2010030220A1 (en) | 2008-09-15 | 2009-09-15 | Cereal suspension |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP2339929A4 (en) |
| SE (1) | SE0801966L (en) |
| WO (1) | WO2010030220A1 (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102960461A (en) * | 2012-11-30 | 2013-03-13 | 江南大学 | Preparation method of oat milk with good taste, color and luster and stability |
| CN105341950A (en) * | 2015-11-05 | 2016-02-24 | 江苏羚羊生物科技有限公司 | Oat dietary fibers capable of reducing blood sugar and preparation method of oat dietary fibers |
| WO2018002335A1 (en) | 2016-06-30 | 2018-01-04 | Teknimed | Bone substitute and independent injection system |
| WO2019122499A1 (en) * | 2017-12-22 | 2019-06-27 | Valio Ltd | Plant-based product and process |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5686123A (en) * | 1993-09-15 | 1997-11-11 | Lindahl; Lennart | Homogeneous and stable cereal suspension and a method of making the same |
| WO2002065855A2 (en) * | 2001-02-15 | 2002-08-29 | Cereal Base Ceba Ab | Non-dairy containing milk substitute products |
| JP2003274852A (en) * | 2002-03-27 | 2003-09-30 | Asahi Denka Kogyo Kk | Yogurt |
| WO2007003688A1 (en) * | 2005-07-04 | 2007-01-11 | Avenly Oy | Food suspension comprising beta-glucan and a method of preparing the same |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6020016A (en) * | 1998-04-01 | 2000-02-01 | The J.M. Smucker Company | Glucan containing beverage and method of making the same |
| US6190708B1 (en) * | 1998-10-19 | 2001-02-20 | Cereal Base Ceba Ab | Enzyme preparations for modifying cereal suspensions |
| US6531178B2 (en) * | 2000-12-08 | 2003-03-11 | Quaker Oats/Rhone-Poulenc Partnership | β-glucan process, additive and food product |
| US20030147993A1 (en) * | 2002-02-01 | 2003-08-07 | Heddleson Ronald A. | Food products with improved bile acid binding functionality and methods for their preparation |
| SE0200735D0 (en) * | 2002-03-13 | 2002-03-13 | Raisio Group Plc | Food and feed composition and process |
| US20070299017A1 (en) * | 2006-06-23 | 2007-12-27 | Kanter Mitchell M | Compositions for lowering blood serum cholesterol and use in foods, beverages, and health supplements |
-
2008
- 2008-09-15 SE SE0801966A patent/SE0801966L/en unknown
-
2009
- 2009-09-15 EP EP09813303A patent/EP2339929A4/en not_active Withdrawn
- 2009-09-15 WO PCT/SE2009/000409 patent/WO2010030220A1/en not_active Ceased
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5686123A (en) * | 1993-09-15 | 1997-11-11 | Lindahl; Lennart | Homogeneous and stable cereal suspension and a method of making the same |
| WO2002065855A2 (en) * | 2001-02-15 | 2002-08-29 | Cereal Base Ceba Ab | Non-dairy containing milk substitute products |
| JP2003274852A (en) * | 2002-03-27 | 2003-09-30 | Asahi Denka Kogyo Kk | Yogurt |
| WO2007003688A1 (en) * | 2005-07-04 | 2007-01-11 | Avenly Oy | Food suspension comprising beta-glucan and a method of preparing the same |
Non-Patent Citations (2)
| Title |
|---|
| DATABASE WPI Week 200381, Derwent World Patents Index; AN 2003-869417, XP003026335 * |
| See also references of EP2339929A4 * |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102960461A (en) * | 2012-11-30 | 2013-03-13 | 江南大学 | Preparation method of oat milk with good taste, color and luster and stability |
| CN102960461B (en) * | 2012-11-30 | 2014-04-02 | 江南大学 | A preparation method of oat milk with good taste, color and stability |
| CN105341950A (en) * | 2015-11-05 | 2016-02-24 | 江苏羚羊生物科技有限公司 | Oat dietary fibers capable of reducing blood sugar and preparation method of oat dietary fibers |
| CN105341950B (en) * | 2015-11-05 | 2019-01-18 | 南京金陵红楼梦生物科技有限公司 | A kind of hypoglycemic Herba bromi japonici dietary fiber and preparation method thereof |
| WO2018002335A1 (en) | 2016-06-30 | 2018-01-04 | Teknimed | Bone substitute and independent injection system |
| WO2019122499A1 (en) * | 2017-12-22 | 2019-06-27 | Valio Ltd | Plant-based product and process |
| CN111491522A (en) * | 2017-12-22 | 2020-08-04 | 维利奥有限公司 | Plant-Based Products and Methods |
| JP2021507708A (en) * | 2017-12-22 | 2021-02-25 | ヴァリオ・リミテッドValio Ltd | Plant-based products and methods |
| JP2023088934A (en) * | 2017-12-22 | 2023-06-27 | オッドリーグッド・グローバル・オサケユフティオ | Plant-based products and methods |
| AU2018392099B2 (en) * | 2017-12-22 | 2024-12-19 | Oddlygood Ltd | Plant-based product and process |
| JP7649942B2 (en) | 2017-12-22 | 2025-03-24 | オッドリーグッド・リミテッド | Plant-Based Products and Methods |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2339929A1 (en) | 2011-07-06 |
| SE532376C2 (en) | 2009-12-29 |
| EP2339929A4 (en) | 2012-03-28 |
| SE0801966L (en) | 2009-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Schmidt | Cereal beta-glucans: An underutilized health endorsing food ingredient | |
| FI114379B (en) | Process for preparing a homogeneous and stable cereal suspension | |
| Biliaderis et al. | Functional food carbohydrates | |
| CN103844185B (en) | Soluble oat or pearling cone meal and utilize the preparation method of enzyme | |
| US9504272B2 (en) | Method of processing oats to achieve oats with an increased avenanthramide content | |
| CN100548155C (en) | Improved dietary fiber containing materials comprising low molecular weight glucans | |
| RU2586152C2 (en) | Method of producing extract based on whole cereal grains | |
| RU2549932C2 (en) | Hydrolysed whole grains containing milk-and-grain beverage for young children | |
| Ahmad et al. | β-Glucan as a food ingredient | |
| RU2597988C2 (en) | Dry instant beverages containing hydrolysed whole grains | |
| Din et al. | Nutritional and functional perspectives of barley β-glucan | |
| CN102651975A (en) | Nutritional products comprising hydrolyzed whole grain | |
| MX2013006506A (en) | DRINKS READY FOR CONSUMPTION THAT INCLUDE HYDROLYZED WHOLE GRAINS. | |
| RU2577356C2 (en) | Filling composition containing hydrolysed whole grains | |
| EP2339929A1 (en) | Cereal suspension | |
| RU2545867C2 (en) | Sublimated snack product containing hydrolysed whole grains | |
| MX2013006510A (en) | Infant cereal products comprising hydrolyzed whole grain. | |
| RU2383253C2 (en) | Liquid fibre composition, method for producing, application and food product thereof | |
| Sharma et al. | Prebiotic and probiotic potential of cereals | |
| WO2012076056A1 (en) | Food product comprising hydrolyzed whole grain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09813303 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2009813303 Country of ref document: EP |